2023 annual financial data

Sutro Biopharma 2023 Operating cash flow

Direct answer

Operating cash flow was -111.62M USD.

Operating income was -89.28M USD and net income was -106.79M USD.
Operating cash flow was -111.62M USD.

Get free Sutro Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
153.73M USD
Operating income
-89.28M USD
Net income
-106.79M USD
Operating cash flow
-111.62M USD